MXC.AX - MGC Pharmaceuticals Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2019
30/06/2018
30/06/2017
Total revenue
2,148
656.237
296.811
120.242
Cost of revenue
1,850
356.642
119.34
158.073
Gross profit
297.796
299.595
177.471
-37.831
Operating expenses
Research development
4,178
2,866
951.323
-
Selling general and administrative
3,375
3,423
3,973
4,472
Total operating expenses
12,980
9,339
7,438
7,282
Operating income or loss
-12,683
-9,039
-7,261
-7,320
Interest expense
-3.071
8
99.369
19.724
Total other income/expenses net
-2,030
6,969
-1,822
-1,290
Income before tax
-14,642
-1,876
-8,990
-8,502
Income tax expense
27.315
27.315
-1.038
0
Income from continuing operations
-14,669
-1,904
-8,989
-8,502
Net income
-14,770
-2,309
-8,246
-8,144
Net income available to common shareholders
-14,770
-2,309
-8,246
-8,144
Basic EPS
-
-0.00
-0.01
-0.01
Diluted EPS
-
-0.00
-0.01
-0.01
Basic average shares
-
1,209,142
1,125,543
966,344
Diluted average shares
-
1,209,142
1,125,543
966,344
EBITDA
-
-1,609
-8,563
-8,399